Becker A, Hoffmeister R T
J Int Med Res. 1980;8(5):333-8. doi: 10.1177/030006058000800505.
Fenbufen, a new butanoic acid derivative with anti-inflammatory properties, was evaluated in an open-label study. It was found that fenbufen was an effective anti-inflammatory agent with tolerable and acceptable potential side-effects. Its advantages appeared to be its long clinical half-life and relatively mild toxicity and/or allergic response.
芬布芬是一种具有抗炎特性的新型丁酸衍生物，在一项开放标签研究中进行了评估。结果发现，芬布芬是一种有效的抗炎药物，具有可耐受且可接受的潜在副作用。其优势似乎在于临床半衰期长以及毒性和/或过敏反应相对较轻。
